Relmada Therapeutics (stock symbol: RLMD) Logo in transparent PNG and SVG formats

Relmada Therapeutics Logo large

Relmada Therapeutics Logo icon format

Relmada Therapeutics Logo large for dark backgrounds

Relmada Therapeutics Logo icon format for dark backgrounds

About Relmada Therapeutics

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

  • Website domain: relmada.com
  • Employees: 10
  • Marketcap: $0.13 Billion USD

Page last updated on:

July 20th, 2022

Categories: